These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27730626)

  • 21. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
    Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
    J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines.
    Fieger CB; Huang MC; Van Brocklyn JR; Goetzl EJ
    FASEB J; 2005 Nov; 19(13):1926-8. PubMed ID: 16148028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
    Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
    Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
    Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells.
    Qi H; Egen JG; Huang AY; Germain RN
    Science; 2006 Jun; 312(5780):1672-6. PubMed ID: 16778060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye.
    Perez VL; Biuckians AJ; Streilein JW
    Ocul Immunol Inflamm; 2000 Mar; 8(1):9-24. PubMed ID: 10806431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions.
    Mehal WZ; Sheikh SZ; Gorelik L; Flavell RA
    Int Immunol; 2005 May; 17(5):531-8. PubMed ID: 15824070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
    Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
    Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
    Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
    Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit.
    Lo CG; Xu Y; Proia RL; Cyster JG
    J Exp Med; 2005 Jan; 201(2):291-301. PubMed ID: 15657295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8+ T cells.
    Stark R; Hartung A; Zehn D; Frentsch M; Thiel A
    Eur J Immunol; 2013 Jun; 43(6):1511-7. PubMed ID: 23765345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo.
    Huleatt JW; Lefrançois L
    J Immunol; 1995 Jun; 154(11):5684-93. PubMed ID: 7751620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
    Hofmann M; Brinkmann V; Zerwes HG
    Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocytes as effector cells: activated Ly-6C(high) mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells.
    Leirião P; del Fresno C; Ardavín C
    Eur J Immunol; 2012 Aug; 42(8):2042-51. PubMed ID: 22585535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.